Belgium Pharmaceuticals & Healthcare Q1 2020

Belgium Pharmaceuticals & Healthcare Q1 2020

Key View:

Continued proposals to contain the healthcare budget through greater control of prescription drug prices have beenmet with broad-based support across the Belgian Federal Parliament. At the same time, the improving standards of care haveresulted in the country being consistently ranked in the top five European nations in several health indices and vindicating long-term reforms put in place to boost healthcare access, quality and outcomes.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Belgium Pharmaceuticals & Healthcare Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Galapagos
Janssen Pharmaceutica
UCB Pharma
Belgium Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook